These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16003864)

  • 1. Investigation of application of PHA coating to enhance biocompatibility of vascular stents.
    Protopopov AV; Kochkina TA; Konstantinov EP; Shishatskaia EI; Efremov SN; Volova TG; Gitelson II
    Dokl Biol Sci; 2005; 401():85-7. PubMed ID: 16003864
    [No Abstract]   [Full Text] [Related]  

  • 2. Major polymer damage of drug-eluting stents.
    Wiemer M; Butz T; Mahmood K; Horstkotte D
    Circ Cardiovasc Interv; 2008 Oct; 1(2):154. PubMed ID: 20031670
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimization of local methylprednisolone delivery to inhibit inflammatory reaction and neointimal hyperplasia of coated coronary stents.
    Huang Y; Wang L; Verweire I; Qiang B; Liu X; Verbeken E; Schacht E; De Scheerder I
    J Invasive Cardiol; 2002 Sep; 14(9):505-13. PubMed ID: 12205348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmable elution profile coating for drug eluting stents.
    Al-Lamee K
    Med Device Technol; 2005 Mar; 16(2):12-5. PubMed ID: 15828493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries.
    Whelan DM; van der Giessen WJ; Krabbendam SC; van Vliet EA; Verdouw PD; Serruys PW; van Beusekom HM
    Heart; 2000 Mar; 83(3):338-45. PubMed ID: 10677417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental evaluation of a new antithrombogenic stent using ion beam surface modification.
    Sugita Y; Suzuki Y; Someya K; Ogawa A; Furuhata H; Miyoshi S; Motomura T; Miyamoto H; Igo S; Nosé Y
    Artif Organs; 2009 Jun; 33(6):456-63. PubMed ID: 19473141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mussel-inspired coating of polydopamine directs endothelial and smooth muscle cell fate for re-endothelialization of vascular devices.
    Yang Z; Tu Q; Zhu Y; Luo R; Li X; Xie Y; Maitz MF; Wang J; Huang N
    Adv Healthc Mater; 2012 Sep; 1(5):548-59. PubMed ID: 23184789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional network-structured film coating for woven and knitted polyethylene terephthalate against cardiovascular graft-associated infections.
    Al Meslmani BM; Mahmoud GF; Sommer FO; Lohoff MD; Bakowsky U
    Int J Pharm; 2015 May; 485(1-2):270-6. PubMed ID: 25796119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the biocompatibility of two new diamond-like stent coatings (Dylyn) in a porcine coronary stent model.
    De Scheerder I; Szilard M; Yanming H; Ping XB; Verbeken E; Neerinck D; Demeyere E; Coppens W; Van de Werf F
    J Invasive Cardiol; 2000 Aug; 12(8):389-94. PubMed ID: 10953100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma-based biofunctionalization of vascular implants.
    Wise SG; Waterhouse A; Kondyurin A; Bilek MM; Weiss AS
    Nanomedicine (Lond); 2012 Dec; 7(12):1907-16. PubMed ID: 23249334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(polyol sebacate) Elastomers as Coatings for Metallic Coronary Stents.
    Navarro L; Mogosanu DE; de Jong T; Bakker AD; Schaubroeck D; Luna J; Rintoul I; Vanfleteren J; Dubruel P
    Macromol Biosci; 2016 Nov; 16(11):1678-1692. PubMed ID: 27500500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymer-based paclitaxel-eluting stents implantation in unprotected left main.
    Colombo A
    Catheter Cardiovasc Interv; 2007 Feb; 69(3):378-9. PubMed ID: 17295282
    [No Abstract]   [Full Text] [Related]  

  • 15. In Vitro and Pilot In Vivo Evaluation of a Bioactive Coating for Stent Grafts Based on Chondroitin Sulfate and Epidermal Growth Factor.
    Lequoy P; Savoji H; Saoudi B; Bertrand-Grenier A; Wertheimer MR; De Crescenzo G; Soulez G; Lerouge S
    J Vasc Interv Radiol; 2016 May; 27(5):753-760.e3. PubMed ID: 27036642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endovascular stents and stent-grafts: is heparin coating desirable?
    Nelson SR; deSouza NM; Allison DJ
    Cardiovasc Intervent Radiol; 2000; 23(4):252-5. PubMed ID: 10960536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immobilization of recombinant human tropoelastin on metals using a plasma-activated coating to improve the biocompatibility of coronary stents.
    Waterhouse A; Yin Y; Wise SG; Bax DV; McKenzie DR; Bilek MM; Weiss AS; Ng MK
    Biomaterials; 2010 Nov; 31(32):8332-40. PubMed ID: 20708259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymer coating techniques for drug-eluting stents.
    al-Lamee K; Cook D
    Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting biodegradable poly-D/L-lactic acid vascular stents: an experimental pilot study.
    Uurto I; Mikkonen J; Parkkinen J; Keski-Nisula L; Nevalainen T; Kellomäki M; Törmälä P; Salenius JP
    J Endovasc Ther; 2005 Jun; 12(3):371-9. PubMed ID: 15943514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.